Adjustment of lipiodol dose according to tumor blood supply during transcatheter arterial chemoembolization for large hepatocellular carcinoma by multidetector helical CT
Adjustment of lipiodol dose according to tumor blood supply during transcatheter arterial chemoembolization for large hepatocellular carcinoma by multidetector helical CT
复制标题
DOI：
10.3748/wjg.v10.i18.2753
复制
发表时间：
2004-09-15
影响因子：
4.3
通讯作者：
Jia, Yu-Chen
中科院分区：
文献类型：
--
作者：
Cheng, Hong-Yan;Shou, Yi;Jia, Yu-Chen
目的：目的：根据CT对大肝癌（HCC）血供的评估，制定个体化TACE中阿比碘油的剂量。肝细胞癌的血供模式分为血供充足、血供不足、混合血供和动静脉分流。超液化碘油的剂量根据肝癌的直径和血供类型而定。根据肿瘤直径及肿瘤血供类型分为碘油灌注组和碘化油灌注组各50例。结果：碘油灌注组和碘化油灌注组的确诊率和有效率分别为82%、84%和36%、46%（P
AIM: To work out an individualized lipiodol dose in transcatheter arterial chemoembolization (TACE) for large hepatocellular carcinoma (HCC) according to its blood supply evaluated by CT.METHODS: One hundred patients with large HCC (more than 8 cm in diameter) were studied by multidetector helical CT. Patterns of blood supply of HCC were divided into sufficient blood supply, poor blood supply, mixed blood supply and arteriovenous (A-V) shunt. The dose of ultra-fluid lipiodol was determined by diameter and blood supply type of HCC. Patients were divided into two groups (50 cases each): lipiodol perfusion group and iodized oil perfusion group according to tumor diameter and the blood supply type of tumor.RESULTS: The confirmation and effective rates were 82%, 84% in the first group and 36%, 46% in the second group (P